Stay updated on Clobetasol Oil in Pediatric Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Clobetasol Oil in Pediatric Atopic Dermatitis Clinical Trial page.

Latest updates to the Clobetasol Oil in Pediatric Atopic Dermatitis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for a pediatric study of clobetasol topical oil for moderate to severe atopic dermatitis. It includes the termination reason, study design and outcomes, eligibility criteria, and study locations.SummaryDifference48%

- Check15 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1. The study record still shows a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 while the study page remains blocked by a 403 error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access message. This indicates an access restriction or site issue rather than a substantive update to the study data.SummaryDifference18%

Stay in the know with updates to Clobetasol Oil in Pediatric Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Clobetasol Oil in Pediatric Atopic Dermatitis Clinical Trial page.